Theory and practice of the use of expectorants reviewed from clinical aspects.
D000111:Acetylcysteine / Q000627:therapeutic use; D001964:Bromhexine / Q000627:therapeutic use; D002233:Carbocysteine / Q000627:therapeutic use; D002923:Cilia / Q000502:physiology; D003371:Cough / Q000503:physiopathology; D005100:Expectorants / Q000009:adverse effects / Q000627:therapeutic use*; D006139:Guaiacol / Q000627:therapeutic use; D006801:Humans; D009093:Mucus / Q000502:physiology; D011092:Polyethylene Glycols / Q000627:therapeutic use; D012140:Respiratory Tract Diseases / Q000188:drug therapy / Q000503:physiopathology; D013183:Sputum / Q000032:analysis; D013729:Terpenes / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use; D014783:Viscosity
D005100:Expectorants; D013729:Terpenes; D011092:Polyethylene Glycols; D006139:Guaiacol; D002233:Carbocysteine; C005385:ozothine; D013806:Theophylline; D001964:Bromhexine; D000111:Acetylcysteine; C016811:tyloxapol